SCIENTIFIC BACKGROUND

CDKN1C, CHD8, DIS3L2, DNMT3A, EED, EZH2, GPC3, HERC1, HIST1H1E, NFIX, NSD1, OFD1, RNF135

Scientific Background

Overgrowth syndromes are a heterogeneous group of diseases with above average (lengthwise) growth in childhood in common. There is currently no formal definition of overgrowth. It can be generalized (concerning the whole body) or segmental (concerning a part of the body). A suggested definition would be: dysmorphic features plus size and head circumference greater than +2 SD (standard deviations), target size (calculated based on the mean size of the parents) greater than +2 SD.

 

The pediatric large growth syndromes include Beckwith-Wiedeman, Sotos, Weaver, Simpson-Golabi-Behmel, Perlman, and Tatton-Brown-Rahman syndromes. The main characteristics are increased pre- and postnatal linear growth, facial abnormalities and partial psychomotor retardation. There are phenotypic overlaps in some syndromes that make clinical differentiation difficult, but there are also characteristic symptoms that suggest a certain suspected diagnosis, such as the combination of large stature, omphalocele and macroglossia in Beckwith-Wiedemann syndrome.

 

Changes in various genes, such as NSD1 (Sotos syndrome 1), NFIX (Sotos syndrome 2) and EZH2 (Weaver syndrome) form the molecular basis of the syndromes, and the investigation of these can help to clarify the differential diagnosis. Tatton-Brown-Rahman syndrome also known as DNMT3A overgrowth syndrome, is caused by pathogenic variants of the DNMT3A gene, which is one of the genes that code for DNA methyltransferase enzymes. Beckwith-Wiedemann syndrome, which is caused by pathogenic variants in CDKN1C, as well as more frequently by epigenetic alterations on the short arm of chromosome 11, is a special case. In some syndromes, there is an increased risk of embryonic tumors, for example, a Wilms tumor in Beckwith-Wiedemann and Perlman syndromes for which specific screening measures are recommended.

 

References

Kamien et al. 2018 Mol Syndromol 9:70 / Tatton-Brown et al. 2017 Am J Hum Genet 100: 725 / da Silva Lacerda et al. 2014, Radiol Res and Pract, Article ID 947451 / Tatton-Brown et al. 2014, Nat Genet 46:385 / Tatton-Brown et al. 2013, Am J Med Genet C Semin Med Genet 163C:71 / Neylon et al. 2012 Curr Opin Pediatr 24:505

 

See also: Sotos syndrome, Weaver syndrome

GENES

CDKN1C, CHD8, DIS3L2, DNMT3A, EED, EZH2, GPC3, HERC1, HIST1H1E, NFIX, NSD1, OFD1, RNF135
How to order

LATEST ARTICLES

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more